Furthermore, TTN, MUC16, CSDM3, RYR2, USH2A, and SYNE1 were frequently mutated in gynecological cancers but not in the MSK-IMPACT samples (Figure 4A), suggesting that they play specific roles in the development of gynecological malignancies. This evidence concerns the gene RYR2 and female reproductive organ cancer.